During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR; Lillian L. Siu, MD, FAACR; and Timothy A. Yap, MBBS, PhD—led a panel discussion with leading voices from industry and venture capital, including Alexis Borisy, MS, cofounder and chairman of the venture capital firm Curie.Bio; Chris Boshoff, MD, PhD, chief scientific officer and president of research and development at Pfizer; and David Schenkein, MD, general partner of the venture capital firm Google Ventures.
The post Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development appeared first on American Association for Cancer Research (AACR).
Source: Oncology
